3.8 Review

Gallbladder cancer: epidemiology and genetic risk associations

Journal

CHINESE CLINICAL ONCOLOGY
Volume 8, Issue 4, Pages -

Publisher

AME PUBLISHING COMPANY
DOI: 10.21037/cco.2019.08.13

Keywords

Gallbladder cancer (GBC); gallbladder neoplasms; epidemiology; molecular genetics; genetic predisposition to disease

Categories

Funding

  1. National Institutes of Health [R01 CA 186566]
  2. Mayo Clinic Hepatobiliary SPORE [P50 CA 210964]
  3. Mayo Clinic Cancer Center [P30 CA 15083]
  4. Mayo Clinic Center for Clinical and Translational Science [UL1 TR 002377]
  5. Cholangiocarcinoma Foundation

Ask authors/readers for more resources

Gallbladder cancer (GBC) is a form of hepatobiliary malignancy that develops from the mucosal lining of the gallbladder. The early development of gallbladder cancer is usually asymptomatic and gallbladder cancer has a high propensity to metastatic dissemination, thus most patients are diagnosed at intermediate to advanced stages for which there is no curative treatment. Consequently, gallbladder cancer is highly lethal. Though the overall global incidence of gallbladder cancer is low, there is marked geographic variation and ethnic communities in Asia as well as Native American populations in both North and South America are affected disproportionately. This article provides a comprehensive overview of the current epidemiology and risk and protective factors associated with gallbladder cancer development. In addition, the current knowledge on environmental and genetic risk associations for gallbladder cancer and the need for additional large-scale genome wide association studies (GWAS) are discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available